| Entity | Vaccine | Grand total |
| European Union | Pfizer, AstraZeneca, Moderna, Novavax, Janssen, Sanofi, CureVac, and Valneva | 2,885,000,000 | COVAX | Pfizer, AstraZeneca, Moderna, Novavax, Janssen, and Sanofi | 2,361,000,000 | USA | Pfizer, AstraZeneca, Moderna, Novavax, Janssen, Sanofi, and Covaxin | 1,210,000,000 | UK | Pfizer, AstraZeneca, Moderna, Novavax, Janssen, Sanofi, CureVac, and Valneva | 517,000,000 | Brazil | Pfizer, AstraZeneca, Moderna, Janssen, Sinovac, Sputnik V, and Covaxin | 450,000,000 | India | AstraZeneca, Novavax, Sputnik V, and Covaxin | 390,000,000 | Canada | Pfizer, AstraZeneca, Moderna, Novavax, Janssen, Sanofi, and Medicago | 381,000,000 | Japan | Pfizer, AstraZeneca, and Moderna | 314,000,000 | African Union | Pfizer, Janssen, and Sputnik V | 270,000,000 | Indonesia | Pfizer, AstraZeneca, Novavax, Sinovac, Sinopharm, and CanSino | 255,500,000 | Turkey | Pfizer, Sinovac, and Sputnik V | 214,500,000 | Mexico | Pfizer, AstraZeneca, Moderna, Novavax, Janssen, Sinovac, Sputnik V, CureVac, Sinopharm, and CanSino | 204,830,000 |
|
|